Fujiwara, Yasuhiro

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

Fujiwara, Y., Mukai, H., Saeki, T., Ro, J., Lin, Y.-C., Nagai, S. E., Lee, K. S., Watanabe, J., Ohtani, S., Kim, S. B., et al. (2019) · British Journal of Cancer

Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery

Cited by 147

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.

Waki, F., Ando, M., Takashima, A., Yonemori, K., Nokihara, H., Miyake, M., Tateishi, U., Tsuta, K., Shimada, Y., Fujiwara, Y., et al. (2009) · Journal of Neuro-Oncology

Brain Metastases and TreatmentManagement of metastatic bone disease

Cited by 145

Feasibility and usefulness of the ‘Distress Screening Program in Ambulatory Care’ in clinical oncology practice

Shimizu, K., Ishibashi, Y., Umezawa, S., Izumi, H., Akizuki, N., Ogawa, A., Fujiwara, Y., Ando, M., Katsumata, N., Tamura, K., et al. (2010) · Psycho-Oncology

Cancer survivorship and carePalliative and Oncologic Care

Cited by 70